Topic: Food and Drug Administration
Propoxyphene, an opioid pain reliever, has been withdrawn by the FDA from the US market because of its potential harmful effects on the cardiovascular system.. Propoxyphene is an opioid or narcotic pain reliever prescribed for mild to moderate pain since it was ...
An estimated 10 million people in the U.S. were prescribed propoxyphene, brand name Darvon, in 2009, according to the Food and Drug Administration (FDA). In November, 2010 the FDA asked Xanodyne Pharmaceuticals to cease marketing of Darvon, and the related brand Darv. ...
Boston Scientific Corporation (BSX) Investor Day Conference Call November 19, 2010 8:00 am ET. Boston Scientific and I'd just use DES here as the example, served market share in developed markets is 31% compared to 6% in emerging markets. Now Dr. Dawkins ...
Drugmaker Xanodyne Pharmaceuticals Inc. agreed Friday to pull two of its painkillers, Darvon and Darvocet, from the US market over heart risk concerns, the US Food and Drug Administration said.Similar withdrawals from the market of the drug also known as propoxyphene were ...
At the request of the U.S. Food and Drug Administration, Xanodyne Pharmaceuticals has agreed to withdraw propoxyphene, an opioid used to treat mild to moderate pain, from the U.S. market due to the risk of potentially serious or even fatal heart rhythm ...
The opioid-based painkillers Darvon and Darvocet are being withdrawn from the U.S. market because they've been linked to serious and potentially deadly heart rhythms, federal officials said Friday.. The U.S. Food and Drug Administration said Xanodyne Pharmaceuticals -- which makes Darvon and ...
The FDA has at last banned Darvon, Darvocet, and other brand/generic drugs containing propoxyphene -- a safety-plagued painkiller from the 1950s.. But the FDA overruled the panel, instead asking Darvon/Darvocet maker Xanodyne Pharmaceuticals Inc. to conduct studies of the drug's effects on ...
Nov. 19--CHICAGO -- A heart drug that was the subject of a Journal Sentinel investigative report earlier this year has been linked to an increasing number of adverse side effects, according to an analysis by a watchdog group that monitors medication errors ...
A new blood thinner might be a viable alternative to warfarin (Coumadin), the standard for decades to treat patients with the dangerous heart rhythm disorder known as atrial fibrillation.. "In October of 2006, the FDA [U.S. Food and Drug Administration] issued a ...
ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced that it has notified the US Food and Drug Administration (FDA) that the company has placed a voluntary hold on PEARL-SC, the Phase 2b study of A-623 ...
Photo Gallery
-
Star Scientific-Smokeless Tobacco
FILE - In this Sept. 28, 2010 file photo, smokeless tobacco products, including ...AP News - -
FDA Obesity Treatments
In this product photograph provided by Allergan, Inc., the LAP-BAND System is ...AP News - -
Congress Food Safety
FILE - In this Oct. 25, 2010 file photo, Sen. Tom Harkin, D-Iowa ...AP News -
From Around the Web
Video Gallery
-
The FDA's New and Improved ...
The US Food and Drug Administration recently unveiled nine graphic ...2011-08-02 -
FDA Disputes TV Suggestion of Apple ...
The federal Food and Drug Administration and toxicologists are disputing ...2011-09-15 -
Dr. Mercola Discusses the FDA
articles.mercola.com Natural health physician and Mercola.com founder ...2011-09-11
